Five-year open-label extension study of safety and efficacy of etanercept in children and adolescents with moderate to severe plaque psoriasis

Authors
Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2016
This article has no abstract
Epistemonikos ID: d67551b3af35b0c256e1ff2440b1bc378967afb8
First added on: Feb 07, 2025